OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Developing nutritional component chrysin as a therapeutic agent: Bioavailability and pharmacokinetics consideration, and ADME mechanisms
Song Gao, Nyma Siddiqui, Imoh Etim, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 142, pp. 112080-112080
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Dispersion-corrected DFT calculations and umbrella sampling simulations to investigate stability of Chrysin-cyclodextrin inclusion complexes
Pramod Kumar, Vijay Kumar Bhardwaj, Rituraj Purohit
Carbohydrate Polymers (2023) Vol. 319, pp. 121162-121162
Closed Access | Times Cited: 41

Targeting neuroinflammation by polyphenols: A promising therapeutic approach against inflammation-associated depression
Mohammed Abu Tayab, Mohammad Nazmul Islam, Kazi Ashfak Ahmed Chowdhury, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 147, pp. 112668-112668
Open Access | Times Cited: 63

Neuroprotective Potential of Chrysin: Mechanistic Insights and Therapeutic Potential for Neurological Disorders
Awanish Mishra, Pragya Shakti Mishra, Ritam Bandopadhyay, et al.
Molecules (2021) Vol. 26, Iss. 21, pp. 6456-6456
Open Access | Times Cited: 57

Propolis: A Detailed Insight of Its Anticancer Molecular Mechanisms
Suhib Altabbal, Khawla Athamnah, Aaesha Rahma, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 3, pp. 450-450
Open Access | Times Cited: 24

Development of dietary small molecules as multi-targeting treatment strategies for Alzheimer's disease
Rengasamy Balakrishnan, Khoshnur Jannat, Dong‐Kug Choi
Redox Biology (2024) Vol. 71, pp. 103105-103105
Open Access | Times Cited: 11

Flavonoids with Anti-Angiogenesis Function in Cancer
Qiang Wei, Yihan Zhang
Molecules (2024) Vol. 29, Iss. 7, pp. 1570-1570
Open Access | Times Cited: 11

Chrysin protects against cerebral ischemia-reperfusion injury in hippocampus via restraining oxidative stress and transition elements
Jinfeng Shang, Jiakang Jiao, Mingxue Yan, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114534-114534
Open Access | Times Cited: 20

Encapsulation of chrysin and rutin using self-assembled nanoparticles of debranched quinoa, maize, and waxy maize starches
Mejo Kuzhithariel Remanan, Fan Zhu
Carbohydrate Polymers (2024) Vol. 337, pp. 122118-122118
Open Access | Times Cited: 7

Chrysin a promising anticancer agent: recent perspectives
Muhammad Shahbaz, Hammad Naeem, Muhammad Imran, et al.
International Journal of Food Properties (2023) Vol. 26, Iss. 1, pp. 2294-2337
Open Access | Times Cited: 14

5,7-Dihydroxyflavone acts on eNOS to achieve hypotensive effects in spontaneously hypertensive rats
Zi-Han Shen, Ye Tao, Baozhen Chen, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access

Advancements and recent explorations of anti-cancer activity of chrysin: from molecular targets to therapeutic perspective
Abhilasha Sood, Arpit Mehrotra, Ujjawal Sharma, et al.
Exploration of Targeted Anti-tumor Therapy (2024) Vol. 5, Iss. 3, pp. 477-494
Open Access | Times Cited: 4

Effect of Chrysin, a Flavonoid Present in Food, on the Skeletal System in Rats with Experimental Type 1 Diabetes
Sylwia Klasik-Ciszewska, Piotr Londzin, Krzysztof Grzywnowicz, et al.
Nutrients (2025) Vol. 17, Iss. 2, pp. 316-316
Open Access

Research Progress in Nutritional Components, Biological Activity, and Processing and Utilization of Chenopodium quinoa Willd
Wei Ding, Yue Liu, Y. B. Liu, et al.
ACS Food Science & Technology (2025)
Closed Access

Anticancer Activity of Ether Derivatives of Chrysin
Arkadiusz Sokal, Patryk Mruczek, Mateusz Niedoba, et al.
Molecules (2025) Vol. 30, Iss. 4, pp. 960-960
Open Access

Flavones and prostate cancer
Sanjib Das, Koushik Sen, Krishnendu Sinha, et al.
Elsevier eBooks (2025), pp. 221-256
Closed Access

Enhanced bioaccessibility and anti-inflammatory effect of chrysin nanoemulsion
Yuna Lee, Eui‐Baek Byun
Journal of Functional Foods (2025) Vol. 128, pp. 106820-106820
Closed Access

Pathophysiology of diabetic hepatopathy and molecular mechanisms underlying the hepatoprotective effects of phytochemicals
Leila Mobasheri, Mitra Ahadi, Ali Beheshti Namdar, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115502-115502
Open Access | Times Cited: 10

Tannic acid coated nanosuspension for oral delivery of chrysin intended for anti-schizophrenic effect in mice
Abeer Salama, Alaa H. Salama, Marwa Hasanein Asfour
International Journal of Pharmaceutics (2024) Vol. 656, pp. 124085-124085
Closed Access | Times Cited: 3

Transient inhibition of mitochondrial function by chrysin and apigenin prolong longevity via mitohormesis in C. elegans
Yu Cheng, Bing-Hao Hou, Guilin Xie, et al.
Free Radical Biology and Medicine (2023) Vol. 203, pp. 24-33
Closed Access | Times Cited: 8

The Amorphous Solid Dispersion of Chrysin in Plasdone® S630 Demonstrates Improved Oral Bioavailability and Antihyperlipidemic Performance in Rats
Chenhui Wang, Xiaowei Liu, Ruihan Zhao, et al.
Pharmaceutics (2023) Vol. 15, Iss. 10, pp. 2378-2378
Open Access | Times Cited: 7

Page 1 - Next Page

Scroll to top